Log In
Print
BCIQ
Print
Print this Print this
 

Brostallicin

  Manage Alerts
Collapse Summary General Information
Company Cell Therapeutics Inc.
DescriptionSynthetic DNA minor groove binding agent
Molecular Target DNA
Mechanism of ActionMinor groove binder
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationBreast cancer
Indication DetailsTreat metastatic triple-negative breast cancer (TNBC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today